arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Fulgent Genetics, Inc.

FLGT Health Care Medical Specialities
$19.99
▼ -1.7% Today
as of Oct 22, 16:48 ET
Last 30 days -3.20% Sep 14 → Oct 22
$19.60 $20.36 $21.13 $21.90 $22.66 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$20.08
High
$20.19
Low
$19.30
Volume
$274,241
Avg Vol
$385,876
Mkt Cap
$566M
P/E (TTM)
—
Beta
—
52w High
$31.04
52w Low
$13.46
Div Yield
—
Shares Out
$28M

Recent Press Releases & News last 60 days · 2 items

Oct 15 · 20:05 PR Business Wire
Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Sep 22 · 17:16 Zacks
PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?

FLGT earnings at a glance

Fulgent Genetics, Inc. (FLGT) is scheduled to report earnings on Friday, November 6, 2026 — in 14 days. Analysts expect earnings per share of $1.00, compared with -$0.16 in the same quarter last year (+725%). The options market is pricing a move of about ±10.8% after the report, a range of roughly $17.83 to $22.15 from today's $19.99. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±18.0% on average; after the most recent report on Jul 30, 2026 it moved -18.1%. That means options currently expect less movement than FLGT has typically delivered. FLGT beat the consensus EPS estimate in 4 of its last 6 reported quarters. Implied volatility is currently 91%. The share price of $19.99 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$13
$31
37% of range
Avg surprise (last 6)
+32.3%
Avg reaction (last 6)
-3.0%
50% positive
Latest IV / EM
91%
EM ±10.8% · $20 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.88$-0.69$-0.49$-0.30$-0.11 Actual $-0.30Est $-0.50Actual $-0.25Est $-0.56Actual $-0.16Est $-0.56Actual $-0.11Est $-0.27Actual $-0.64Est $-0.53Actual $-0.88Est $-0.79 Mar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$-30M$267,112$30M$60M$90M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Jul 30, 2026Jun/2026 $-0.88 $-0.79 -11.4% -216.0% -18.1% earnings
Fri May 1, 20268K 2026-05-01 $-0.64 $-0.53 -20.8% — -7.0% earnings
Fri Feb 27, 20268K 2026-02-27 $-0.11 $-0.27 +59.3% — -38.1% earnings
Fri Nov 7, 2025Sep/2025 $-0.16 $-0.56 +71.4% — +18.2% earnings
Fri Aug 1, 2025Jun/2025 $-0.25 $-0.56 +55.4% — +7.9% earnings
Fri May 2, 2025Mar/2025 $-0.30 $-0.50 +40.0% — +19.1% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Fri Nov 6, 2026Sep/2026OTHER $1.00-$0.16 +725.0%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$85M$71M—$84M$82M$73M—$72M
Cost of revenue$60M$50M—$49M$47M$45M—$45M
Gross profit$26M$21M—$36M$34M$28M—$27M
Operating income$-36M$-35M—$-15M$-20M$-20M—$-17M
Net income$-30M$-25M—$-7M$-19M$-12M—$-15M
EPS (diluted)————————

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$26M$23M$50M$118M$88M$67M$55M$58M
Inventory$793,000$770,000——————
Total current assets$455M$479M$550M$507M$429M$417M$354M$327M
Total assets$1.09B$1.16B$1.21B$1.21B$1.20B$1.21B$1.22B$1.23B
Long-term debt————————
Total liabilities$93M$112M$107M$94M$88M$83M$91M$99M
Total equity$1.00B$1.04B$1.11B$1.13B$1.11B$1.12B$1.13B$1.13B

Implied volatility — last 90 days

15%91%166%242%317% Jun 07 — IV 77% · EM ±10.7%Jun 08 — IV 120% · EM ±15.8%Jun 09 — IV 70% · EM ±8.8%Jun 10 — IV 186% · EM ±21.9%Jun 11 — IV 128% · EM ±14.1%Jun 12 — IV 141% · EM ±14.5%Jun 15 — IV 218% · EM ±15.8%Jun 16 — IV 207% · EM ±12.2%Jun 17 — IV 318% · EM ±13.3%Jun 19 — IV 47% · EM ±10.4%Jun 22 — IV 48% · EM ±9.9%Jun 23 — IV 51% · EM ±10.5%Jun 24 — IV 61% · EM ±12.2%Jun 25 — IV 25% · EM ±4.9%Jun 26 — IV 50% · EM ±9.5%Jun 29 — IV 66% · EM ±11.7%Jun 30 — IV 61% · EM ±10.5%Jul 01 — IV 65% · EM ±10.8%Jul 02 — IV 59% · EM ±9.6%Jul 03 — IV 61% · EM ±9.6%Jul 06 — IV 125% · EM ±17.3%Jul 07 — IV 103% · EM ±13.6%Jul 08 — IV 77% · EM ±9.7%Jul 09 — IV 107% · EM ±12.7%Jul 10 — IV 70% · EM ±7.8%Jul 13 — IV 120% · EM ±10.0%Jul 14 — IV 84% · EM ±6.1%Jul 15 — IV 161% · EM ±9.5%Jul 16 — IV 239% · EM ±10.0%Jul 20 — IV 73% · EM ±17.3%Jul 21 — IV 65% · EM ±15.2%Jul 22 — IV 67% · EM ±15.2%Jul 23 — IV 78% · EM ±17.5%Jul 24 — IV 82% · EM ±18.0%Jul 27 — IV 81% · EM ±16.9%Jul 28 — IV 100% · EM ±20.4%Jul 29 — IV 84% · EM ±16.8%Jul 30 — IV 105% · EM ±20.5%Jul 31 — IV 73% · EM ±14.0%Aug 03 — IV 62% · EM ±10.9%Aug 04 — IV 54% · EM ±9.3%Aug 05 — IV 65% · EM ±10.8%Aug 06 — IV 64% · EM ±10.4%Aug 10 — IV 95% · EM ±13.1%Aug 11 — IV 139% · EM ±18.4%Aug 12 — IV 100% · EM ±12.6%Aug 13 — IV 84% · EM ±9.9%Aug 14 — IV 117% · EM ±12.9%Aug 17 — IV 99% · EM ±8.3%Aug 18 — IV 130% · EM ±9.4%Aug 19 — IV 269% · EM ±15.9%Aug 24 — IV 65% · EM ±13.6%Aug 25 — IV 61% · EM ±12.4%Aug 26 — IV 55% · EM ±11.0%Aug 27 — IV 42% · EM ±8.3%Aug 28 — IV 34% · EM ±6.5%Aug 31 — IV 58% · EM ±10.3%Sep 01 — IV 43% · EM ±7.4%Sep 02 — IV 46% · EM ±7.6%Sep 03 — IV 46% · EM ±7.4%Sep 04 — IV 47% · EM ±7.3%Sep 07 — IV 53% · EM ±7.3%Sep 08 — IV 44% · EM ±5.8%Sep 09 — IV 48% · EM ±6.0%Sep 10 — IV 45% · EM ±5.3%Sep 11 — IV 55% · EM ±6.1%Sep 14 — IV 93% · EM ±7.7%Sep 15 — IV 167% · EM ±12.1%Sep 21 — IV 51% · EM ±10.7%Sep 22 — IV 78% · EM ±15.9%Sep 23 — IV 87% · EM ±17.4%Sep 24 — IV 47% · EM ±9.2%Sep 25 — IV 16% · EM ±3.0%Sep 28 — IV 35% · EM ±6.3%Sep 29 — IV 48% · EM ±8.3%Sep 30 — IV 48% · EM ±7.9%Oct 01 — IV 87% · EM ±14.1%Oct 02 — IV 76% · EM ±11.9%Oct 05 — IV 86% · EM ±11.9%Oct 06 — IV 72% · EM ±9.5%Oct 07 — IV 83% · EM ±10.5%Oct 08 — IV 91% · EM ±10.8%

Sector peers

BDSX
Biodesix, Inc.
$279M $23.94+0.3%
TLSI
TriSalus Life Sciences, Inc.
$256M $3.660.0%
XGN
Exagen Inc.
$201M $7.48+0.9%
BNR
Burning Rock Biotech Limited
$143M $13.25+4.7%
CSTL
Castle Biosciences, Inc.
$1.0B $33.19+0.1%
KEQU
Kewaunee Scientific Corporation
$105M $32.38-1.6%

FLGT earnings FAQ

When is FLGT's next earnings date?

Fulgent Genetics, Inc. is expected to report on November 6, 2026.

What is FLGT's expected move for earnings?

Options currently price a move of about ±10.8%, or $2.16 per share either way from $19.99.

How does FLGT stock usually react to earnings?

Across the last 6 reports the average next-day move was ±18.0%, up 3 times and down 3 times.

What EPS are analysts expecting from Fulgent Genetics, Inc.?

The consensus estimate is $1.00 per share, versus -$0.16 a year ago.

What is FLGT's implied volatility?

FLGT's at-the-money implied volatility is about 91% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in